Doggweiler R. .2017 ."A Standard for Terminology in Chronic Pelvic Pain Syndromes: A Report from the Chronic Pelvic Pain Working Group of the. International Continence Society." Neurourology and Urodynamics 36.4, : 984-1008.
Malde S. .2018 ."Guideline of Guidelines: Bladder Pain Syndrome.". , 122 : 729-743.
Kumar P. .2024 .: e0298981. " PLOS ONE 19.2, 029898 : 1.
Clemens J. Q. .2022 ."Diagnosis and Treatment of Interstitial Cystitis/Bladder Pain Syndrome.". Journal of Urology 208.1, : 00000000000027-56.
Kowalczyk P. .2021 ."Mitochondrial Oxidative Stress-A Causative Factor and Therapeutic Target in Many Diseases.". International Journal of Molecular Sciences 22.24, : 13384.
Akiyama Y.,Perspectives Future .2021 ."Biomarkers in Interstitial Cystitis/Bladder Pain Syndrome with and without Hunner Lesion: A Review. " Diagnostics, 11 : 2238.
Lin H. Y. .2021 .. "Urinary Biomarkers in Interstitial Cystitis/Bladder Pain Syndrome and Its Impact on Therapeutic Outcome." Diagnostics 12.1, : 75.
Webster J. D.,Vucic D. .2020 ."The Balance of TNF Mediated Pathways Regulates Inflammatory Cell Death Signaling in Healthy and Diseased Tissues." Frontiers in Cell and Developmental Biology 8 (. , 00365 : 365.
Apaijai N. .2020 ."Cognitive Impairment Is Associated with Mitochondrial Dysfunction in Peripheral Blood Mononuclear Cells of Elderly Population.". Scientific Reports 10.1, : 21400.
Ajaz S. .2020 ."Mitochondrial Dysfunction as a Mechanistic Biomarker in Patients with NonAlcoholic Fatty Liver Disease (NAFLD. " Mitochondrion, 12 : 119-130.
Patnaik S. S. .2017 ."Etiology, Pathophysiology and Biomarkers of Interstitial Cystitis/Painful Bladder Syndrome.". Archives of Gynecology and Obstetrics, 295 : 1341-1359.
Willig A. L. .2017 ."Monocyte Bioenergetic Function Is Associated with Body Composition in Virologically Suppressed HIV-Infected Women.". Redox Biology, 04 : 648-656.
Berry S. H. .2011 ."Prevalence of Symptoms of Bladder Pain Syndrome/Interstitial Cystitis among Adult Females in the United States.". The Journal of Urology 186.2, 03 : 540-544.
Mendonça F. T.,Placebo-Controlled Trial F. T. .2020 .". Brazilian Journal of Anesthesiology, 12 : 233-240.
Sheng Z. M. .2024 .". International Journal of Surgery 110.2, 13(2024) : 920-838.
Aksoy M.,Placebo-Controlled Trial M. .2021 ."Granisetron or Ondansetron to Prevent Hypotension after Spinal Anesthesia for Elective Cesarean Delivery:. " Journal of Clinical Anesthesia, 1104 : 110469.
Mohamed S. .2021 ."Effectiveness of Prophylactic Ondansetron in Preventing Spinal Anesthesia Induced Hypotension and Bradycardia in Pregnant Mother Undergoing Elective Cesarean Delivery: A Double Blinded Randomized Control Trial.". International Journal of Surgery Open, 100401 : 100401.
Zhang Y. .2024 ."Intravenous Ondansetron for the Prevention of Supine Hypotensive Syndrome during Spinal Anesthesia for Cesarean Section: A Randomized Controlled Trial." Frontiers in Pharmacology 15 (. , 1194196 : 1194196.
Sharma S. N.,Maravi G. S. .2020 ."Effect of Ondansetron in Prevention of Hypotension in Elective Lower Segment Cesarean Section under Spinal Anesthesia: A Randomized, Double-Blind Study.". International Journal of Scientific Study, 7(11) : 89-98.
El-Rahman A. .2023 ."Evaluation of the Efficacy of Ondansetron in Preventing Post Spinal Anesthesia Hypotension in Cesarean Sections.". Benha Journal of Applied Sciences 8.8, 228234 : 225-50.